Advertisement
Screener

SAFECODE DRUG TECHNOLOGIES CORP. Operating Cash Flow

SAFECODE DRUG TECHNOLOGIES CORP. Operating Cash Flow

SAFECODE DRUG TECHNOLOGIES CORP. reported Operating Cash Flow of -$359.98 thousand for the 31-month period ending 2013-06-30, per its 10-Q filed 2013-08-13.

Discontinued › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2013-08-13

  • SAFECODE DRUG TECHNOLOGIES CORP. net cash provided by (used in) operating activities for the quarter ending 2013-06-30 was $171.63K.
  • SAFECODE DRUG TECHNOLOGIES CORP. net cash provided by (used in) operating activities for the quarter ending 2013-03-31 was -$207.42K.
  • SAFECODE DRUG TECHNOLOGIES CORP. net cash provided by (used in) operating activities for the quarter ending 2012-12-31 was -$68.42K.
  • SAFECODE DRUG TECHNOLOGIES CORP. net cash provided by (used in) operating activities for the quarter ending 2012-09-30 was -$17.01K.
  • SAFECODE DRUG TECHNOLOGIES CORP. net cash provided by (used in) operating activities for fiscal 2012 was -$98.14K.
  • SAFECODE DRUG TECHNOLOGIES CORP. net cash provided by (used in) operating activities for fiscal 2011 was -$23.91K.
Period endNet Cash Provided by (Used in) Operating Activities 1 monthNet Cash Provided by (Used in) Operating Activities 3 monthNet Cash Provided by (Used in) Operating Activities 6 monthNet Cash Provided by (Used in) Operating Activities 9 monthNet Cash Provided by (Used in) Operating Activities 12 monthNet Cash Provided by (Used in) Operating Activities 13 monthNet Cash Provided by (Used in) Operating Activities 16 monthNet Cash Provided by (Used in) Operating Activities 19 monthNet Cash Provided by (Used in) Operating Activities 22 monthNet Cash Provided by (Used in) Operating Activities 25 monthNet Cash Provided by (Used in) Operating Activities 28 monthNet Cash Provided by (Used in) Operating Activities 31 month
2013-06-30$171.63K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-13
-$35.79K
10-Q · filed 2013-08-13
-$104.21K
derived: sum of 3 quarters · filed 2013-08-13
-$121.22K
derived: sum of 4 quarters · filed 2013-08-13
-$359.98K
10-Q · filed 2013-08-13
2013-03-31-$207.42K
10-Q · filed 2013-05-10
-$275.85K
derived: sum of 2 quarters · filed 2013-05-10
-$292.85K
derived: sum of 3 quarters · filed 2013-05-10
-$304.48K
derived: sum of 4 quarters · filed 2013-08-13
-$336.69K
10-Q · filed 2013-05-10
2012-12-31-$68.42K
derived: 10-K 12 month − 10-Q/A 9 month · filed 2013-03-25
-$85.43K
derived: sum of 2 quarters · filed 2013-03-25
-$97.06K
derived: sum of 3 quarters · filed 2013-08-13
-$98.14K
10-K · filed 2013-03-25
-$129.27K
10-K · filed 2013-03-25
2012-09-30-$17.01K
derived: 10-Q/A 9 month − 10-Q 6 month · filed 2012-12-18
-$28.64K
derived: sum of 2 quarters · filed 2013-08-13
-$29.71K
10-Q/A · filed 2012-12-18
-$43.27K
derived: sum of 4 quarters · filed 2013-08-13
-$60.85K
10-Q/A · filed 2012-12-18
2012-06-30-$11.63K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-13
-$12.71K
10-Q · filed 2013-08-13
-$26.27K
derived: sum of 3 quarters · filed 2013-08-13
-$27.57K
derived: sum of 4 quarters · filed 2013-08-13
-$43.84K
10-Q/A · filed 2012-12-18
2012-03-31-$1.08K
10-Q · filed 2013-05-10
-$14.64K
derived: sum of 2 quarters · filed 2013-05-10
-$15.94K
derived: sum of 3 quarters · filed 2013-05-10
-$15.94K
derived: sum of 4 quarters · filed 2013-05-10
-$32.21K
10-Q · filed 2012-05-15
2011-12-31-$13.56K
derived: 10-K 12 month − 10-Q/A 9 month · filed 2013-03-25
-$14.86K
derived: sum of 2 quarters · filed 2013-03-25
-$14.86K
derived: sum of 3 quarters · filed 2013-03-25
-$23.91K
10-K · filed 2013-03-25
-$31.14K
10-K · filed 2012-03-29
2011-09-30-$1.30K
derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2012-12-18
-$1.30K
derived: sum of 2 quarters · filed 2012-12-18
-$10.35K
10-Q/A · filed 2012-12-18
2011-06-30$0.00
derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-12-18
-$9.05K
10-Q/A · filed 2012-12-18
2011-03-31-$9.05K
10-Q · filed 2012-05-15
2010-12-31-$7.23K
10-K · filed 2012-03-29